These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23671030)

  • 1. Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.
    Peng S; Ma Y; Spetsieris PG; Mattis P; Feigin A; Dhawan V; Eidelberg D
    Hum Brain Mapp; 2014 May; 35(5):1801-14. PubMed ID: 23671030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    Carli G; Meles SK; Reesink FE; de Jong BM; Pilotto A; Padovani A; Galbiati A; Ferini-Strambi L; Leenders KL; Perani D
    Neuroimage Clin; 2023; 39():103475. PubMed ID: 37494757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of image reconstruction algorithms on topographic characteristics, diagnostic performance and clinical correlation of metabolic brain networks in Parkinson's disease.
    Tomše P; Peng S; Pirtošek Z; Zaletel K; Dhawan V; Eidelberg D; Ma Y; Trošt M
    Phys Med; 2018 Aug; 52():104-112. PubMed ID: 30139598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease.
    Tomše P; Jensterle L; Rep S; Grmek M; Zaletel K; Eidelberg D; Dhawan V; Ma Y; Trošt M
    Phys Med; 2017 Sep; 41():129-135. PubMed ID: 28188080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease-related network topographies characterized with resting state functional MRI.
    Vo A; Sako W; Fujita K; Peng S; Mattis PJ; Skidmore FM; Ma Y; Uluğ AM; Eidelberg D
    Hum Brain Mapp; 2017 Feb; 38(2):617-630. PubMed ID: 27207613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of disease-related spatial covariance patterns using neuroimaging data.
    Spetsieris P; Ma Y; Peng S; Ko JH; Dhawan V; Tang CC; Eidelberg D
    J Vis Exp; 2013 Jun; (76):. PubMed ID: 23851955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in network activity with the progression of Parkinson's disease.
    Huang C; Tang C; Feigin A; Lesser M; Ma Y; Pourfar M; Dhawan V; Eidelberg D
    Brain; 2007 Jul; 130(Pt 7):1834-46. PubMed ID: 17470495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectral guided sparse inverse covariance estimation of metabolic networks in Parkinson's disease.
    Spetsieris PG; Eidelberg D
    Neuroimage; 2021 Feb; 226():117568. PubMed ID: 33246128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal network topographies and changes in global activity: absence of a causal relationship.
    Dhawan V; Tang CC; Ma Y; Spetsieris P; Eidelberg D
    Neuroimage; 2012 Dec; 63(4):1827-32. PubMed ID: 22951259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic correlates of metabolic network activity in Parkinson's disease.
    Holtbernd F; Ma Y; Peng S; Schwartz F; Timmermann L; Kracht L; Fink GR; Tang CC; Eidelberg D; Eggers C
    Hum Brain Mapp; 2015 Sep; 36(9):3575-85. PubMed ID: 26037537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging.
    Teune LK; Renken RJ; de Jong BM; Willemsen AT; van Osch MJ; Roerdink JB; Dierckx RA; Leenders KL
    Neuroimage Clin; 2014; 5():240-4. PubMed ID: 25068113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic brain networks associated with cognitive function in Parkinson's disease.
    Huang C; Mattis P; Tang C; Perrine K; Carbon M; Eidelberg D
    Neuroimage; 2007 Jan; 34(2):714-23. PubMed ID: 17113310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility.
    Ma Y; Tang C; Spetsieris PG; Dhawan V; Eidelberg D
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):597-605. PubMed ID: 16804550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaled Subprofile Modeling and Convolutional Neural Networks for the Identification of Parkinson's Disease in 3D Nuclear Imaging Data.
    Manzanera OM; Meles SK; Leenders KL; Renken RJ; Pagani M; Arnaldi D; Nobili F; Obeso J; Oroz MR; Morbelli S; Maurits NM
    Int J Neural Syst; 2019 Nov; 29(9):1950010. PubMed ID: 31046514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features.
    Spetsieris PG; Ma Y; Dhawan V; Eidelberg D
    Neuroimage; 2009 May; 45(4):1241-52. PubMed ID: 19349238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging.
    Wu P; Wang J; Peng S; Ma Y; Zhang H; Guan Y; Zuo C
    Parkinsonism Relat Disord; 2013 Jun; 19(6):622-7. PubMed ID: 23529021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
    Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features.
    Mudali D; Teune LK; Renken RJ; Leenders KL; Roerdink JB
    Comput Math Methods Med; 2015; 2015():136921. PubMed ID: 25918550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.
    Kim JS; Cho H; Choi JY; Lee SH; Ryu YH; Lyoo CH; Lee MS
    PLoS One; 2015; 10(7):e0132585. PubMed ID: 26147749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.